Nov 19, 2024 · Astellas Pharma Inc. announced the United States Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for avacincaptad pegol intravitreal …

Apr 2, 2024 · Age-related macular degeneration (AMD) is among the leading causes of vision loss. For this reason, many companies see the importance of developing treatment options …

Dec 11, 2024 · Exegenesis Bio provided an update on the company’s treatment candidates for wet age-related macular degeneration (wet AMD). EXG102 is an investigational gene therapy …

Jan 3, 2025 · The Data and Safety Monitoring Board (DSMB) for the OCU410 ArMaDa clinical trial convened and approved continuation of the second phase of the Phase 1/2 study.

Dec 21, 2024 · A research team from Great Britain identified factors, such as mental health issues, lack of diabetic eye screening awareness, and transport difficulties, that interfere with …

Nov 13, 2024 · Imaging techniques to differentiate papilledema from ODD . Several different OCT measurements have been postulated to help differentiate ODD/pseudopapilledema from …

Nov 12, 2024 · The US Food & Drug Administration (FDA) has authorized marketing of Valeda Light Delivery System for treatment of patients with dry age-related macular degeneration (AMD).

Dec 26, 2024 · In 2024, Modern Retina covered news from around the globe on clinical trials, technology in retina, trending topics in ophthalmology, and retina conferences. Let’s look back …

Oct 18, 2024 · Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual …

Oct 20, 2024 · Christine N. Kay, MD, discussed her presentation, "Deuterated vitamin A preserves vision in Stargardt’s disease (TEASE study)" which was given at this year's American …